Cardiff Oncology (CRDF) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free CRDF Stock Alerts $4.37 -0.13 (-2.89%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cardiff Oncology Short Interest DataCurrent Short Volume3,410,000 sharesPrevious Short Volume2,810,000 sharesChange Vs. Previous Month+21.35%Dollar Volume Sold Short$18.21 millionShort Interest Ratio / Days to Cover2.0Last Record DateMarch 31, 2024Outstanding Shares44,680,000 sharesPercentage of Shares Shorted7.63%Today's Trading Volume827,721 sharesAverage Trading Volume1,541,845 sharesToday's Volume Vs. Average54% Short Selling Cardiff Oncology ? Sign up to receive the latest short interest report for Cardiff Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRDF Short Interest Over TimeCRDF Days to Cover Over TimeCRDF Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Cardiff Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20243,410,000 shares $18.21 million +21.4%N/A2 $5.34 3/15/20242,810,000 shares $14.13 million +144.4%N/A1.8 $5.03 2/29/20241,150,000 shares $2.03 million -3.4%N/A0.9 $1.77 2/15/20241,190,000 shares $2.08 million -7.8%N/A7.6 $1.75 1/31/20241,290,000 shares $2.01 million +13.2%N/A7.5 $1.56 1/15/20241,140,000 shares $1.93 million -13.6%N/A6.5 $1.69 Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,320,000 shares $1.95 million -2.2%N/A6.4 $1.48 12/15/20231,350,000 shares $1.89 million -6.9%N/A2 $1.40 11/30/20231,450,000 shares $1.78 million -9.4%N/A2.1 $1.23 11/15/20231,600,000 shares $1.94 million -1.8%N/A2.3 $1.21 10/31/20231,630,000 shares $1.74 million +6.5%N/A2.2 $1.07 10/15/20231,530,000 shares $1.70 million -24.6%N/A1.4 $1.11 9/30/20232,030,000 shares $2.82 million +201.6%N/A1.9 $1.39 9/15/2023673,000 shares $1.16 million +25.4%N/A1.1 $1.73 8/31/2023536,500 shares $987,160.00 -19.5%N/A0.9 $1.84 8/15/2023666,400 shares $1.33 million +28.7%N/A1.2 $2.00 7/31/2023517,700 shares $916,329.00 +5.0%N/A1 $1.77 7/15/2023492,900 shares $694,989.00 -8.2%N/A3.3 $1.41 6/30/2023537,000 shares $789,390.00 +1.0%N/A3.5 $1.47 6/15/2023531,600 shares $845,244.00 -1.7%N/A3.4 $1.59 5/31/2023541,000 shares $871,010.00 -0.2%N/A2.9 $1.61 5/15/2023542,300 shares $949,025.00 -12.1%N/A2.7 $1.75 4/30/2023616,900 shares $1.07 million -2.4%N/A2.9 $1.74 4/15/2023632,000 shares $941,680.00 +1.2%N/A3 $1.49 3/31/2023624,300 shares $1.03 million -7.3%N/A2.6 $1.65 3/15/2023673,600 shares $1.16 million -1.6%N/A2.6 $1.72 2/28/2023684,400 shares $1.18 million -14.6%N/A2.9 $1.73 2/15/2023801,300 shares $1.50 million -11.6%N/A3.3 $1.87 1/31/2023905,900 shares $1.62 million -9.4%N/A3.6 $1.79 1/15/20231,000,000 shares $1.53 million -8.3%N/A3.9 $1.53 12/30/20221,090,000 shares $1.53 million -5.2%N/A4.6 $1.40 12/15/20221,150,000 shares $1.61 million -2.5%N/A4.4 $1.40 11/30/20221,180,000 shares $1.88 million -1.7%N/A2.3 $1.59 11/15/20221,200,000 shares $1.61 million -7.7%N/A2.2 $1.34 10/31/20221,300,000 shares $2.12 million -19.8%N/A2.2 $1.63 10/15/20221,620,000 shares $2.49 million -10.0%N/A2.6 $1.54 9/30/20221,800,000 shares $2.77 million -18.2%N/A2.7 $1.54 9/15/20222,200,000 shares $3.67 million +9.5%N/A2.5 $1.67 8/31/20222,010,000 shares $5.41 million -7.4%N/A2.2 $2.69 8/15/20222,170,000 shares $6.55 million +4.3%N/A2.3 $3.02Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story CRDF Short Interest - Frequently Asked Questions What is Cardiff Oncology's current short interest? Short interest is the volume of Cardiff Oncology shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 3,410,000 shares of CRDF short. Learn More on Cardiff Oncology's current short interest. What is a good short interest ratio for Cardiff Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDF shares currently have a short interest ratio of 2.0. Learn More on Cardiff Oncology's short interest ratio. Which institutional investors are shorting Cardiff Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cardiff Oncology: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cardiff Oncology's short interest increasing or decreasing? Cardiff Oncology saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,410,000 shares, an increase of 21.4% from the previous total of 2,810,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cardiff Oncology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cardiff Oncology: Kodiak Sciences Inc. (3.76%), Century Therapeutics, Inc. (7.62%), Opthea Limited (0.22%), Innate Pharma S.A. (0.10%), Acumen Pharmaceuticals, Inc. (2.88%), Elevation Oncology, Inc. (12.58%), Poseida Therapeutics, Inc. (6.70%), Compass Therapeutics, Inc. (1.97%), X4 Pharmaceuticals, Inc. (7.34%), Graphite Bio, Inc. (2.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Cardiff Oncology stock? Short selling CRDF is an investing strategy that aims to generate trading profit from Cardiff Oncology as its price is falling. CRDF shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cardiff Oncology? A short squeeze for Cardiff Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDF, which in turn drives the price of the stock up even further. How often is Cardiff Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDF, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Kodiak Sciences Short Squeeze Century Therapeutics Short Squeeze Opthea Short Squeeze Innate Pharma Short Squeeze Acumen Pharmaceuticals Short Squeeze Elevation Oncology Short Squeeze Poseida Therapeutics Short Squeeze Compass Therapeutics Short Squeeze X4 Pharmaceuticals Short Squeeze Graphite Bio Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRDF) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlace